1 of 1
Story summary
- The U.S. government will promote research into ibogaine's safety and effectiveness, while ibogaine remains a Schedule I substance.
- U.S. President Donald Trump is expected to sign an executive order to unlock federal funding for ibogaine studies, including veterans' research.
- Texas supports ibogaine research.
- A 2023 review notes potential benefits but serious cardiac risks, with at least 27 deaths, and calls for further rigorous trials.
